MedPath

Glucose Response in Persons with Type 2 Diabetes

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Other: Oral nutrition supplement - test
Other: Oral nutrition supplement - control
Registration Number
NCT04914559
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

This will be a randomized crossover design with oral nutrition supplement interventions.

Detailed Description

This will be a randomized crossover design with two oral nutrition supplement interventions. The subjects will be randomized to one of two interventions on two separate study days, one week apart.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Age 20-75 years
  • Type 2 diabetes controlled with diet or diet and metformin (Glucophage)
  • Hemoglobin A1C less than 9.0%
  • Fasting blood glucose less than 180 mg/dl
  • Hematocrit levels within normal limits
  • Having obtained his/her informed consent
Exclusion Criteria
  • Abnormal thyroid function
  • Creatinine >2.0 mg/dl
  • Potassium <3.5 mEq/l
  • Gastrointestinal disease: ulcer, gastritis, diarrhea, gastroparesis, vomiting
  • Currently unstable diabetes or under treatment for cancer, heart disease, renal disease
  • Patients with anemia
  • Current insulin therapy or insulin therapy within the past month
  • Patient who are pregnant
  • Allergies to milk, soy or any component of the test product
  • Patient who in the investigators assessment cannot be expected to comply with treatment
  • Patients with anemia
  • Currently participating in another clinical trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Oral Nutrition Supplement TestOral nutrition supplement - testThe test study intervention is an oral drink that contain protein, carbohydrate and fat and are intended for use as supplemental nutrition for people living with diabetes.
Oral Nutrition Supplement ControlOral nutrition supplement - controlThe control study intervention is an oral drink that contain protein, carbohydrate and fat and are intended for use as supplemental nutrition.
Primary Outcome Measures
NameTimeMethod
Area under the blood glucose curveBaseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes

Area under the blood glucose curve (AUC 0-240 minutes)

Secondary Outcome Measures
NameTimeMethod
Insulinogenic indexBaseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes

Insulinogenic index (change in Ins30/change in Glu30)

Area under the insulin curveBaseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes

Area under the insulin curve (AUC 0-240 minutes)

Trial Locations

Locations (1)

Orange County Research Center

🇺🇸

Tustin, California, United States

© Copyright 2025. All Rights Reserved by MedPath